Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in rats

By Sato K.   Taniuchi Y.   Kawasaki T.   Hirayama F.   Koshio H.   Matsumoto Y.  

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

YM-60828, a novel factor Xa inhibitor: Separation of its antithrombotic effects from its prolongation of bleeding time

By Sato K.   Kawasaki T.   Taniuchi Y.   Hirayama F.   Koshio H.   Matsumoto Y.  

European Journal of Pharmacology, Vol. 339, Iss. 2, 1997-11 ,pp. : 141-146

Elsevier

Access to resources Recommend Favorite

Antithrombotic activity of AT-1015, a potent 5-HT 2A receptor antagonist, in rat arterial thrombosis model and its effect on bleeding time

By Kihara H.   Koganei H.   Hirose K.   Yamamoto H.   Yoshimoto R.  

European Journal of Pharmacology, Vol. 433, Iss. 2, 2001-12 ,pp. : 157-162

Elsevier

Access to resources Recommend Favorite

Antiplatelet and Antithrombotic Activity of Cilostazol is Potentiated by Dipyridamole in Rabbits and Dissociated from Bleeding Time Prolongation

By Li Haiquan   Cone James   Fong Miranda   Kambayashi Junichi   Yoshitake Masuhiro   Liu Yongge  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 1, 2005-01 ,pp. : 41-48

Springer Publishing Company

Access to resources Recommend Favorite

Antithrombotic effect of a humanized anti-GPIIb/IIIa monoclonal antibody, YM207, in a photochemically induced thrombosis model in monkeys

By Kaku S.   Kawasaki T.   Sakai Y.   Taniuchi Y.   Yano S.   Suzuki K.-i.   Terazaki C.   Kawamura K.   Masuho Y.   Satoh N.   Takenaka T.   Yanagi K.   Ohshima N.  

European Journal of Pharmacology, Vol. 279, Iss. 2, 1995-06 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite